LARIMAR THERAPEUTICS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -78.6% | -78.6% | -64.4% |
| FY2022 | -31.9% | -31.9% | -28.0% |
| FY2023 | -45.2% | -45.2% | -38.5% |
| FY2024 | -46.9% | -46.9% | -40.3% |
| FY2025 | -212.2% | -212.2% | -113.6% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -78.6% | -78.6% | -64.4% |
| FY2022 | -31.9% | -31.9% | -28.0% |
| FY2023 | -45.2% | -45.2% | -38.5% |
| FY2024 | -46.9% | -46.9% | -40.3% |
| FY2025 | -212.2% | -212.2% | -113.6% |